Table of Contents
Overview
Definition and Scope
Rheumatology is a specialized branch of medicine focused on the evaluation, diagnosis, and management of musculoskeletal disorders and connective tissue diseases, which include various forms of arthritis and soft tissue lesions.[1.1] This field encompasses over 100 complex diseases collectively referred to as rheumatic diseases, characterized by inflammation affecting the bones, muscles, joints, and internal organs.[3.1] Rheumatologists, who are physicians trained specifically in this area, employ a range of treatment modalities, including analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic agents such as monoclonal antibodies.[3.1] The scope of rheumatology extends beyond just arthritis; it also includes autoimmune diseases such as lupus and Sjögren's syndrome.[4.1] The Division of Rheumatology at institutions like the Mayo Clinic is recognized for its patient-centered approach and significant contributions to the understanding and treatment of rheumatic diseases.[2.1] Historically, the Mayo Clinic has been at the forefront of rheumatology, having established the first organized training program in this field in the 1920s, which has since evolved to enhance the quality of care provided to patients.[5.1]Common Diseases and Conditions
Rheumatology encompasses a variety of diseases and conditions, with rheumatoid arthritis (RA) being the most prevalent inflammatory arthritis. RA is characterized by its genetic overlap with other autoimmune and inflammatory disorders, particularly associated with the HLA-DRB1 locus, which has been recognized for decades, alongside recent discoveries that have expanded our understanding of its genetic architecture and risk factors.[16.1] The differential diagnosis of subacute or chronic polyarthritic diseases, including RA, involves recognizing specific patterns of changes in clinical features. Key aspects of this diagnostic process include a thorough clinical history and physical examination, which are crucial for distinguishing RA from other connective tissue diseases. For instance, rheumatic fever can be differentiated from RA by its migratory nature of arthritis and a notable response to aspirin.[7.1] Non-rheumatologists have identified patient history and physical examination as the most important diagnostic tools for RA, emphasizing their significance in clinical practice.[9.1] In managing RA, physical therapy plays a vital role in improving patients' quality of life. It addresses specific challenges faced by individuals with RA, such as pain management and enhancement of joint function, thereby promoting long-term joint health.[10.1] Tailoring physical therapy interventions to meet the unique needs of each RA patient is essential, as the disease manifests differently in individuals. This customization is facilitated through initial evaluations that assess functional capabilities and behavioral aspects related to the disease.[13.1] Recent advancements in genetic research have significantly influenced the understanding of autoimmune disorders within rheumatology. The development of next-generation sequencing technologies has transformed the diagnosis of immune-mediated rheumatic diseases, making molecular diagnostics more accessible and effective.[15.1] Additionally, biologic therapies targeting specific components of the immune system have revolutionized RA treatment, offering new management options that prevent chronic tissue destruction.[17.1]History
Early Developments in Rheumatology
The origins of rheumatology can be traced back to ancient times, with diseases such as gout and osteoarthritis being prevalent among early populations. Evidence of these conditions has been found in many ancient skeletons, indicating their long-standing impact on human health.[43.1] The term "rheumatology" itself is derived from the word "rheuma," meaning flowing, which is mentioned in the Hippocratic corpus, highlighting the historical significance of these conditions in medical literature.[46.1] In the early 19th century, significant advancements were made in the understanding of rheumatic diseases. Landré Beauvais provided the primary scientific description of rheumatoid arthritis in 1800, characterizing it by symptoms such as aches and stiffness.[42.1] This period marked the beginning of a more systematic approach to studying rheumatic conditions. The mid-19th century saw further contributions to the field, notably by Alfred Baring Garrod, who, in 1848, delivered a public lecture that established key insights into the causation of rheumatic diseases.[42.1] This era laid the groundwork for future research and clinical practices in rheumatology. The 20th century brought transformative changes, particularly with the introduction of glucocorticoids in the 1950s, which revolutionized treatment approaches in clinical medicine.[48.1] The establishment of the International Committee on Rheumatism in 1925 by Jan van Breeman marked a pivotal moment in the organization and advancement of rheumatology as a distinct medical specialty.[44.1]Recent Advancements
Innovative Therapies and Treatments
Recent advancements in rheumatology have led to the development of innovative therapies and treatments that significantly enhance patient care and outcomes. The year 2024 has been particularly notable for breakthroughs in the management of autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). These advancements encompass innovative therapies, early detection methods, and technological integrations that collectively improve patient outcomes and quality of life.[80.1] Historically, treatment options for rheumatoid arthritis were limited, often resulting in inevitable functional decline and joint deformity for patients diagnosed before the 1990s. At that time, the primary treatments included long-term glucocorticoids and non-steroidal anti-inflammatory drugs (NSAIDs), which were associated with significant toxicity.[81.1] However, the introduction of new therapeutic strategies, including Janus kinase (JAK) inhibitors, has transformed the treatment landscape. These therapies require careful screening and monitoring for potential adverse effects, such as infections and cardiovascular disorders, emphasizing the need for a more nuanced approach to treatment.[83.1] The prognosis for patients with rheumatoid arthritis has improved dramatically due to these new therapies and approaches. Nevertheless, this rapid expansion of treatment options has created challenges for rheumatologists, as the volume of clinically useful information from trials has not kept pace with the introduction of new therapies.[85.1] Furthermore, the complexity of rheumatic disease pathophysiology complicates the identification, development, and evaluation of new therapies, necessitating a redesign of clinical trials to accommodate the diverse responses to treatment among patients.[86.1] In addition to pharmacological advancements, genetic testing and biomarker identification are playing increasingly vital roles in personalizing treatment plans for patients with autoimmune diseases. Genetic testing can assist in diagnosing conditions such as ankylosing spondylitis and Behçet's disease, while also promoting treatment safety and guiding therapeutic decisions.[96.1] Biomarkers serve as essential tools for improving disease classification and risk stratification, ultimately leading to more personalized treatment strategies.[99.1] The integration of these advancements into clinical practice underscores the shift towards precision medicine in rheumatology, which aims to tailor treatments to individual genetic and molecular profiles.[99.1]Technological Integrations in Patient Care
Recent advancements in rheumatology have significantly integrated technology into patient care, particularly through the use of artificial intelligence (AI) and telemedicine. AI technologies, including machine learning (ML) and deep learning (DL), are revolutionizing various aspects of rheumatology, enhancing diagnosis, treatment personalization, and prognosis prediction for rheumatologic diseases. These technologies facilitate screening, monitoring, risk assessment, and drug discovery, thereby broadening the understanding of disease pathophysiology and optimizing treatment outcomes for conditions such as rheumatoid arthritis.[91.1] Moreover, the implementation of AI in rheumatology research has led to improved workflows, drug discovery processes, and clinical trial designs, showcasing its transformative potential in the field.[89.1] The ability of AI to analyze vast amounts of data allows for more accurate diagnoses and tailored treatment plans, which is crucial in managing the complexities of rheumatologic diseases.[88.1] In addition to AI, telemedicine has emerged as a vital tool in rheumatology, particularly highlighted during the COVID-19 pandemic when it was rapidly adopted to meet the clinical needs of patients with rheumatic diseases.[115.1] Telemedicine offers an alternative to traditional face-to-face consultations, improving accessibility for patients and alleviating the stress associated with in-person visits.[114.1] It enables rheumatologists to provide care to a broader patient population, including those in remote areas, thus enhancing the overall patient experience.[117.1] Digital monitoring tools have also been integrated into patient care, allowing for self-management and remote counseling, which have shown to improve patients' self-management abilities over time.[116.1] These tools facilitate patient-initiated follow-up appointments and enhance shared decision-making by providing better quality data, ultimately reducing the need for in-person visits for patients with stable disease activity.[117.1] The combination of these technological advancements is reshaping the landscape of rheumatology, making patient care more efficient and personalized.In this section:
Diagnosis And Management
Diagnostic Methods
Effective diagnosis of rheumatoid arthritis (RA) is crucial for timely management and improved patient outcomes. The diagnostic process typically involves a combination of clinical evaluation, laboratory tests, and imaging studies, which together form the foundation for effective treatment strategies.[122.1] Early identification of RA is essential, as it can lead to significant long-term benefits, including reduced joint damage and improved functional ability.[154.1] Primary care physicians (PCPs) play a vital role in recognizing early signs and symptoms of RA, which may include fatigue, fever, weight loss, stiffness, swelling, and pain in the hands and wrists.[137.1] Training and resources aimed at enhancing the ability of PCPs to identify these early indicators are critical. For instance, the American College of Rheumatology has developed an online resource, "Rheumatology for Primary Care," which provides tools and guidance for identifying rheumatic diseases and implementing early treatment strategies.[156.1] Recent advancements in biomarkers have also contributed to the early diagnosis of RA. Key biomarkers used in routine clinical practice include rheumatoid factor, autoantibodies against citrullinated proteins, erythrocyte sedimentation rate, and C-reactive protein.[125.1] The multi-biomarker disease activity test is another significant development that aids in assessing disease activity and guiding treatment decisions.[125.1] Studies have shown that specific biomarkers, such as microRNA levels, can correlate with disease activity and may help predict clinical outcomes.[124.1]Treatment Modalities
Rheumatoid arthritis (RA) management encompasses a variety of treatment modalities aimed at alleviating symptoms, improving joint function, and enhancing the overall quality of life for patients. Physical therapy plays a crucial role in this multifaceted approach. It employs tailored techniques to manage pain and improve mobility, specifically designed to meet the individual needs of RA patients. These interventions can include exercises that enhance joint function and support overall joint health, thereby alleviating symptoms associated with the disease.[129.1] Research indicates that structured exercise programs, such as dynamic and isometric strengthening exercises, can significantly improve muscle strength without adversely affecting disease activity.[128.1] Additionally, aquatic therapy has been shown to be beneficial for some patients, providing a low-impact environment conducive to rehabilitation.[128.1] By incorporating physical therapy into their treatment plans, individuals with RA can experience increased independence and improved physical function, which are essential for enhancing their quality of life.[129.1] In addition to physical therapy, patient education and self-management strategies are integral components of RA treatment. These strategies empower patients to take an active role in managing their condition, which can lead to better health outcomes. The European League Against Rheumatism (EULAR) emphasizes the importance of self-management in improving the overall quality of life for RA patients, as it helps them cope with the disease's physical and emotional challenges.[134.1] Programs that focus on self-management, such as e-learning platforms, have been developed to enhance patients' understanding of their condition and improve their self-management skills.[133.1] Multidisciplinary care is another vital aspect of RA management. The integration of various healthcare professionals, including rheumatologists, physical therapists, and patient educators, has been shown to improve patient outcomes significantly. Studies suggest that multidisciplinary team (MDT) care can enhance disease management, physical health, and psychosocial well-being, making it an optimal strategy for RA treatment.[144.1] Despite the challenges in implementing such comprehensive care due to resource demands, the benefits of MDT approaches in improving health-related quality of life (HR-QOL) for RA patients are well-documented.[144.1]In this section:
Interprofessional Collaboration
Role of the Healthcare Team
Interprofessional collaboration in rheumatology involves a diverse healthcare team that includes general practitioners, specialists, occupational and physical therapists, nursing services, and other professional groups, all working together to provide comprehensive care for patients with rheumatoid arthritis and other rheumatic diseases.[157.1] This collaborative approach is essential as it allows for a team-based perspective in patient care, where multiple health workers with varying professional backgrounds can effectively address the shifting needs of patients.[159.1] To facilitate effective collaboration, it is crucial for all team members to understand each other's roles within the interdisciplinary team. The ARP Interprofessional Practice & Management Committee has initiated projects to clarify the modern roles of team members, thereby enhancing mutual understanding and cooperation.[167.1] Effective communication is a cornerstone of this collaboration, as nurses often act as the communication bridge between patients, families, and other healthcare professionals, advocating for patient needs and ensuring that care plans are collaboratively formulated and documented.[164.1] However, challenges persist in interprofessional communication, particularly between general practitioners (GPs) and rheumatology specialists. Studies indicate that there are inconsistencies in verbal communication among team members, which can lead to conflicting information being provided to patients.[168.1] To address these issues, strategies such as early diagnosis, quick access to rheumatology care, and improved communication protocols have been recommended to enhance the referral process and overall patient management.[170.1] Ultimately, the success of interprofessional collaboration in rheumatology hinges on building a foundation of collegiality, mutual trust, and respect among team members, which fosters open communication and shared decision-making.[166.1] By prioritizing these elements, healthcare teams can work more effectively to improve patient outcomes and adapt to the evolving needs of individuals with rheumatic diseases.[164.1]Challenges In Rheumatology
Access to Care
Access to healthcare for patients with rheumatic diseases is significantly hindered by various challenges, particularly in developing countries and rural areas. Disparities in access to healthcare professionals, including primary care providers and specialists such as rheumatologists, can lead to delays in diagnosis and treatment initiation, which are crucial for minimizing disease progression and improving patient outcomes.[202.1] The International League of Associations for Rheumatology (ILAR) has recognized these issues and provides limited grants to enhance rheumatology education and clinical practice in developing regions, yet the resources available are insufficient to meet the growing demand.[202.1] A workforce study by the American College of Rheumatology in 2015 projected a 100% mismatch between the demand for rheumatology providers and the available supply by 2030, exacerbating the challenges faced by patients seeking care.[203.1] The increasing prevalence of rheumatic diseases, driven by an ageing population, further intensifies the burden on healthcare systems globally.[204.1] The lack of trained rheumatology clinicians is a common issue across various countries, contributing to a significant healthcare gap that leaves many patients without timely access to effective care.[206.1] Geographic barriers also play a critical role in limiting access to care, particularly for patients living in rural areas. These patients often face longer travel times to reach healthcare facilities, which can deter them from seeking necessary treatment.[213.1] Furthermore, existing disparities in care access and quality among underserved populations are not well understood, highlighting the need for targeted interventions to address these inequities.[207.1] Delays in diagnosis and treatment initiation can have profound impacts on disease outcomes and functional ability for patients with conditions such as rheumatoid arthritis (RA). Research indicates that minimizing delays from symptom onset to therapy initiation is essential to prevent joint damage and improve overall health outcomes.[210.1] Therefore, addressing these access challenges is critical for enhancing the quality of care and treatment outcomes for patients with rheumatic diseases. Policy changes, such as revamping Medicare physician payments and implementing programs to improve healthcare access in underserved areas, are essential steps toward mitigating these challenges.[214.1] Additionally, improving medical education and integrating rheumatology into medical school curricula can help address the workforce shortage, ultimately enhancing patient access to care.[223.1]Future Directions
Emerging Research Areas
Emerging research areas in rheumatology are increasingly focused on innovative therapeutic approaches, advanced technologies, and the integration of artificial intelligence (AI) to enhance patient care and outcomes. One significant direction is the exploration of the safety and cardiovascular pharmacological mechanisms of anti-rheumatoid drugs, particularly targeted synthetic disease-modifying antirheumatic drugs (DMARDs). This area is gaining attention as researchers aim to conduct long-term, robust, and well-designed clinical trials to better understand these therapies' effects.[250.1] The application of machine learning is another promising frontier in rheumatology research. This technology is being utilized to analyze large datasets, which can help identify patients at high risk of developing autoimmune diseases, thereby facilitating early intervention and prevention trials.[251.1] Furthermore, AI's strengths can be leveraged throughout the patient pathway, from diagnosis and disease classification to treatment and monitoring. For instance, deep learning algorithms can identify patient clusters that may respond differently to various biologic and targeted therapies, ultimately improving treatment outcomes and minimizing adverse effects.[293.1] In addition to these technological advancements, there is a growing recognition of the need for collaborative research efforts, particularly in low-resource settings. The underdevelopment of rheumatology research in these areas poses challenges to healthcare access and patient outcomes.[254.1] Collaborative initiatives can enhance the external validity of international recommendations and ensure that interventions are applicable and effective in diverse contexts.[255.1] Moreover, developing models of care that utilize all categories of health workers and identifying cost-effective management strategies are essential for addressing the unique challenges faced in low-resource environments.[256.1] As the global rheumatology community continues to expand its research efforts, the focus on innovative topics previously unexplored is expected to increase, paving the way for transformative advancements in the field.[257.1]Potential Innovations in Treatment
Recent advancements in rheumatology have highlighted the importance of incorporating patient-reported outcomes (PROs) into clinical research and practice. This trend aims to better measure and address what patients truly care about, particularly as patient satisfaction becomes a key metric for overall quality of care.[259.1] Engaging patients in various aspects of research, such as agenda setting, outcome research, and treatment recommendations, is crucial for developing effective strategies that meet their needs and preferences.[261.1] Patient and public involvement (PPI) is expected to provide valuable insights from patients' experiences, which can help identify barriers to treatment adherence and lead to more meaningful outcomes.[262.1] In terms of innovative therapies, recent studies have identified several promising new treatments for rheumatoid arthritis (RA). For instance, peresolimab, an antibody that stimulates the PD-1 pathway, has shown potential as a new approach for RA treatment.[263.1] Additionally, Janus kinase (JAK) inhibitors, including Rinvoq, Olumiant, and Xeljanz, represent a significant advancement in RA therapy by blocking specific enzymes in the JAK-STAT signaling pathway.[264.1] Furthermore, a new biodegradable polymer system has been developed, utilizing advanced immunoengineering techniques to combat arthritis.[265.1] These innovative treatments target specific components of the immune system, offering a more effective approach compared to traditional therapies.[266.1] Ongoing research and clinical trials are essential for assessing the safety and efficacy of these novel therapies, which aim to overcome the limitations of conventional treatments and tailor approaches to individual patients.[267.1] The advent of biologic therapies that specifically target immune system components has transformed RA management, providing new options that prevent chronic tissue destruction.[268.1] Moreover, the integration of artificial intelligence (AI) and machine learning (ML) into rheumatology holds significant promise for enhancing diagnosis and treatment. AI algorithms can assist in various aspects of patient care, including screening, diagnosis, treatment response assessment, and monitoring disease progression.[269.1] Machine learning techniques are particularly valuable for identifying patterns within complex biomedical data, which can improve classification, diagnosis, and treatment predictions for rheumatic diseases.[271.1] The potential for AI to analyze clinical data, medical imaging, and laboratory results presents a significant opportunity for improving diagnosis and prognosis in rheumatology.[272.1] Overall, the application of AI in rheumatology is expected to enhance the understanding of diseases and improve the accuracy of diagnoses and treatment strategies.[273.1]In this section:
Therapeutic ApproachesAttentionPatient-reported OutcomesClinical ResearchPatient Satisfaction
References
[1] Rheumatology - an overview | ScienceDirect Topics — Abstract. Rheumatology is a branch of medicine devoted to the evaluation, diagnosis, and management of musculoskeletal disorders or other connective diseases, including arthritis and sort tissue lesions. This chapter emphasizes diagnosis, evaluation, medical management, and rehabilitation of arthritis. For diagnosis of arthritis, a combination of history-taking and physical examination is the
[2] Overview - Rheumatology - Mayo Clinic Research — Overview. The Division of Rheumatology, part of Mayo Clinic's Department of Medicine, is internationally recognized for its patient-centered approach and contributions to rheumatic disease understanding and treatment. Faculty members in the division have expertise in several areas and specialize in one of three main categories:
[3] Rheumatology - Wikipedia — Rheumatology (from Greek ῥεῦμα (rheûma) 'flowing current') is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones, muscles, joints, and internal organs. Rheumatology covers more than 100 different complex diseases, collectively known as rheumatic diseases, which includes many forms of arthritis as well as lupus and Sjögren's syndrome. Doctors who have undergone formal training in rheumatology are called rheumatologists. Most rheumatic diseases are treated with analgesics, NSAIDs (nonsteroidal anti-inflammatory drug), steroids (in serious cases), DMARDs (disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept, and methotrexate for moderate to severe rheumatoid arthritis. The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis. Physiotherapy is vital in the treatment of many rheumatological disorders.
[4] PDF — RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center. What is Rheumatology? • Medical science devoted to the rheumatic diseases and musculoskeletal disorders • Study of : -autoimmune diseases
[5] Rheumatology - Overview - Mayo Clinic — Mayo Clinic's Division of Rheumatology has a long history of exceptional care. In the 1920's, the first organized training program in rheumatic diseases for physicians was developed at Mayo Clinic. A few decades later, Mayo Clinic rheumatologist and division chair, Dr. Philip S. Hench, shared the Nobel Prize for helping discover the beneficial
[7] Rheumatoid Arthritis (RA) Differential Diagnoses - Medscape — Differentiation of rheumatoid arthritis (RA) from other diseases of connective tissue can be difficult; however, certain clinical features are helpful. Rheumatic fever is characterized by the migratory nature of the arthritis, an elevated anti-streptolysin O titer, and a more dramatic and prompt response to aspirin.
[9] The rheumatological history - Medicine — Taking a thorough history is an important part of clinical practice in rheumatology. The attending doctor should set aside the time necessary to obtain a detailed history from a patient suspected of having a rheumatic disease, taking into account the multisystem nature of these conditions. A thorough history may also help to focus the physical examination and investigations; testing for every
[10] Physical Therapy and Exercise for Rheumatoid Arthritis: Benefits and Tips — Benefits of Physical Therapy for RA Patients. Physical therapy significantly benefits individuals with Rheumatoid Arthritis , helping them manage symptoms and improve their quality of life. By addressing the specific challenges RA patients face, physical therapy helps manage pain, enhances joint function, and promotes long-term joint health
[13] Physical Activity, Exercise Can Benefit Patients with RA — When it comes to physical therapy, physiotherapists (PTs) provide insightful knowledge. PTs rely on physical (e.g., functional, range of motion, muscle strength, or postural) and behavioristic assessments (e.g., behaviors associated with fear-avoidance beliefs) when tailoring interventions to increase bodily function or physical activity in general. 2,4-6 When a home-exercise program is
[15] Principles of clinical genetics for rheumatologists: clinical ... — Advances in DNA sequencing technologies, especially next-generation sequencing (NGS), which is the basis for whole-exome sequencing (WES) and whole-genome sequencing (WGS), have profoundly transformed immune-mediated rheumatic disease diagnosis. Recently, substantial cost reductions have facilitated access to these diagnostic tools, expanded the capacity of molecular diagnostics and enabled
[16] Recent advances in the genetics of rheumatoid arthritis - PMC — To review the recently discovered genetic risk loci in rheumatoid arthritis (RA), the pathways they implicate, and the genetic architecture of RA. Since 2008 investigators have identified many common genetic variants that confer disease risk through
[17] Unlocking the Future: New Biologic Therapies for Rheumatoid Arthritis — The advent of biologic therapies that target specific immune system components (e.g., cytokines, T cells) has transformed RA treatment by offering new management options. Keywords: biologic therapy, disease-modifying antirheumatic drugs (dmards), gene therapy, interleukin blockers, rheumatoid arthritis (ra), tnf inhibitors Unlike traditional DMARDs, biologic DMARDs specifically target immune system cells or proteins involved in the inflammatory process, effectively preventing the chronic destruction of synovial and other tissues caused by RA. In the present review, we discuss the potential of emerging RA biologic therapy centered on RASF (rheumatoid arthritis synovial fibroblasts) triggering molecules, B cell activating factor (BAFF), a protein of the tumor necrosis factor (TNF) family, and alarmins S100 calcium-binding protein A7 (S100A7, also known as psoriasin) and IL-36α in the pathogenesis of RA.
[42] Tracing our roots: on the relevance of rheumatology history — Table 1 Timeline of some milestones in the history of rheumatology. Full size table. In this regard, Landré Beauvais wrote the primary scientific description of rheumatoid arthritis, characterized by aches and stiffness, in 1800 . In 1848, Alfred Baring Garrod, in a public lecture, established his main contribution to the causation of
[43] History of rheumatology - DOAJ — This article describes the history and various milestones of rheumatology from ancient to modern times. The origin of rheumatology can be traced to ancient times. Diseases such as gout and osteoarthritis were prevalent in ancient people. Many ancient skeletons show signs of gout and osteoarthritis.
[44] Rheumatology: A Brief History - The Rheumatologist — Rheumatology: A Brief History - The Rheumatologist An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals ACR ACR Open Rheumatology Arthritis & Rheumatology Rheumatology: A Brief History Soon, the transatlantic crossing was made, and in 1949, the dramatic effect of cortisone was described by Philip Hench, MD, before a few hundred of us at the Annual Meeting of the American Rheumatism Association, the precursor of the ACR. After that, the field of rheumatology interested both research-oriented and practice-oriented doctors. A Brief History of American Rheumatology American rheumatology traces its origins nine decades back to Europe, when the International Committee on Rheumatism was founded by Jan van Breeman in 1925 at a European meeting of medical…
[46] Medical Journal of Dr. D.Y. Patil University - LWW — s. The ancient book on Indian Medicine, Charaka Samhita, gives a vivid description of many variants of arthritis. Charaka, an eminent Ayurvedic physician, described rheumatoid arthritis (RA) in Charaka Samhitha as "Vishkantha," meaning painful joints. The word rheumatology has its origin in the word "rheuma," which means flowing, and is mentioned in Hippocratic corpus. Hippocrates made several
[48] Challenging issues in rheumatology: thoughts and perspectives — Rheumatology's modern history can be characterized by defining themes, and challenges, in each decade, to which we have adapted well (Table 1). The introduction of glucocorticoids by Philip Hench and colleagues at the Mayo Clinic in the 1950s transformed clinical medicine . The 1960s saw the establishment, development, and growth of
[80] 2024: A Transformative Year in Rheumatology Research and Innovation — The year 2024 has been marked by significant advancements in rheumatology, offering new hope for patients with conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and other autoimmune diseases. These breakthroughs span innovative therapies, early detection methods, and technological integrations, collectively enhancing patient care and outcomes. Innovative
[81] Therapeutic advances in rheumatoid arthritis - The BMJ — Advances in treatment: a historical overview Until the 1990s, a diagnosis of rheumatoid arthritis implied inevitable functional decline and joint deformity. Options for treatment were limited, and many patients received long term glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs), or both, with their associated toxicity.
[83] Recent progress in treatments of rheumatoid arthritis: an overview of ... — Patients treated with JAK inhibitors should be adequately screened and monitored for infection, cardiovascular disorders, thrombosis, malignancies and so on. Advances in therapeutic strategies, including the differential use of therapeutic drugs and de-escalation of treatment after remission induction, are prioritized.
[85] Challenges in clinical trial design in inflammatory arthritis — The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic
[86] Hurdles in new drug development in rheumatic diseases — We highlight the challenges presented by incomplete understanding of the complexity of rheumatic disease pathophysiology and the resultant difficulties in the identification, development, and evaluation of new therapies. We further explore the diversity of the underlying disease processes leading to heterogeneity in patient response to treatment, necessitating the re-design of clinical trials
[88] Artificial intelligence in rheumatology research: what is it good for ... — Abstract. Artificial intelligence (AI) is transforming rheumatology research, with a myriad of studies aiming to improve diagnosis, prognosis and treatment prediction, while also showing potential capability to optimise the research workflow, improve drug discovery and clinical trials.
[89] Editorial: Artificial intelligence in rheumatology and musculoskeletal ... — The field of artificial intelligence (AI) in medicine has evolved dramatically over the past decade, paving the way for ground-breaking innovation. ... Together, these reviews underscore the transformative impact of AI in various facets of rheumatology, from diagnosis to treatment optimization and imaging standardization.
[91] Artificial intelligence in rheumatology - ScienceDirect — Current examples of artificial intelligence implementation in rheumatology Machine learning applications in diagnosis In recent years substantial breakthroughs using AI/ML applications have been made in the field of rheumatology, including disease prevention, diagnosis, prognosis, drug discovery and clinical trial design ( Fig. 20.2 ).
[96] The Role of Genetics in Rheumatic Diseases — Genetic testing can help identify individuals at higher risk of developing these conditions, allowing for early intervention and preventive measures. Additionally, understanding the genetic basis of rheumatic diseases can guide treatment decisions and improve patient outcomes.
[99] PDF — of personalized medicine, which tailors treatment to an individual's genetic and molecular profile. This article explores the emerging trends in the treatment of AIRD, focusing on the shift towards precision medicine. It examines the impact of biological therapies, genetic testing, and the role of biomarkers in guiding treatment decisions.
[114] Telehealth in Rheumatology » Rheumatologist OnCall — This blog explores the benefits of telehealth in rheumatology, the impact of virtual consultations, ... and improved patient experience. Patients no longer face the stress of rushed appointments or financial uncertainties. With telemedicine, rheumatologists can provide expert care to a broader patient population, from metropolitan areas to the
[115] Lessons on Telemedicine in Rheumatology - Rheumatic Disease Clinics — During the COVID-19 pandemic, telemedicine was rapidly deployed to meet the clinical needs of patients with rheumatic diseases worldwide. Rheumatologists were forced to care for patients with all rheumatic diseases, regardless of disease activity, and limited evidence was available to guide provider decision-making regarding telemedicine appropriateness for outpatient rheumatology encounters
[116] Effect of digital monitoring and counselling on self-management ability ... — Keywords: rheumatoid arthritis, e-health, self-monitoring, physical activity, self-management, patient activation. Graphical abstract. Open in a new tab. Rheumatology key messages. Digital self-monitoring tools with remote counselling by a physiotherapist improved self-management ability after 27 weeks.
[117] Digital remote monitoring in rheumatology: using health economics to ... — Digital remote monitoring is appealing for health-care systems facing growing pressures from the rising costs of care and constrained workforce capacity to meet the demand for rheumatology services. Patient-initiated follow-up (PIFU) appointments, better quality data to improve shared decision making, and fewer in-person appointments for people with low disease activity all become feasible
[122] Comprehensive Rheumatology Care - ResApp Innovations — Key Points. Comprehensive rheumatology care involves a holistic approach to managing rheumatic diseases. A thorough diagnosis is the foundation of effective treatment, requiring a combination of clinical evaluation, laboratory tests, and imaging studies. Rheumatologists play a critical role in the diagnosis and management of rheumatic diseases.
[124] Novel biomarkers in RA: Implication for diagnosis, prognosis, and ... — Regarding the use of genetic and epigenetic biomarkers to assess disease activity, a meta-analysis published in 2018 examining the potential role of microRNA miR-146a levels in the serum, synovial fluid or tissue as a marker of disease activity in RA, found that miR-146a levels were higher in RA patients and showed a significant positive correlation with ESR, but not with Disease Activity Score for 28 joints (DAS28) . Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial
[125] Biomarkers in Rheumatoid Arthritis - PMC - PubMed Central (PMC) — The utilization and identification of biomarkers in rheumatoid arthritis (RA) to facilitate timely diagnosis and the optimal management of the disease is an area of active investigation. This review focuses on the four biomarkers included in these criteria that are available for routine clinical use: rheumatoid factor, autoantibodies against citrullinated proteins, erythrocyte sedimentation rate, and C-reactive protein; the multi-biomarker disease activity test is also discussed. ACR/EULAR, American College of Rheumatology/European League Against Rheumatism; RF, rheumatoid factor; anti-CCP2, anti-cyclic citrullinated peptide2; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; MBDA, multi-biomarker disease activity test; DAS28, Disease Activity Score 28; SDAI, Simplified Disease Activity Index 46.Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
[128] Rehabilitation Management for Rheumatoid Arthritis Patients — Rehabilitation Management for the Rheumatoid Arthritis Patients from Johns Hopkins Arthritis In several studies, van den Ende et al (van den Ende, 1996 and 2000) showed that short term intense exercise program consisting of dynamic and isometric strengthening and bicycling could improve muscle strength without deleterious effect on disease activity. Danneskiold-Samsoe et al (ref 2) studied a small group of patients to assess the effect of exercise in a heated pool. Hakkinen et al (ref 7) examined the aerobic capacity of physically active females with early or long-term rheumatoid arthritis and healthy women. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Effect of intensive exercise on patients with active rheumatoid arthritis: a randomized clinical trial.
[129] The Role of Physical Therapy in Rheumatoid Arthritis Management — By incorporating physical therapy into their treatment plan, individuals with RA can experience improved physical function, increased independence, and a better quality of life. Tailoring Physical Therapy Interventions to Individual Rheumatoid Arthritis Patients. Each individual with rheumatoid arthritis experiences the disease differently
[133] The Importance of Self-Management in Rheumatoid Arthritis for Better Health — Now, let's talk about one of the most important elements in managing rheumatoid arthritis: self-management. This is where you, as the patient, play a significant role in your day-to-day life with RA. While medications can help control inflammation and pain, self-management strategies are what really help make a difference in the long run.
[134] Empowering Self-Management in Inflammatory Arthritis: The Role of the — EULAR emphasizes the importance of self-management in improving the overall quality of life for patients with rheumatoid arthritis (RA). The disease's activity, structural damage, and progression can deeply affect a patient's life and contribute to substantial psychosocial distress.
[137] Signs and Symptoms of Rheumatoid Arthritis - Healthline — Early symptoms of rheumatoid arthritis can include bodily pain and weakness. But after weeks or months, you may develop other symptoms, such as joint swelling. Symptoms may vary from person to person.
[144] Multidisciplinary team care for people with rheumatoid arthritis: a ... — Rheumatoid arthritis (RA) impairs function and quality of life [] and causes a huge personal and societal economic burden [].Comprehensive and effective management is vital. Multidisciplinary team (MDT) care aims to improve disease, physical and psychosocial outcomes and is considered the optimal care strategy for people with RA [].Whilst the configuration of the team and mode of delivery
[154] Early Diagnosis of Rheumatoid Arthritis in Primary Care — Early diagnosis and treatment of rheumatoid arthritis (RA) has been found to lead to long-term improved outcomes in recent years. 1 Primary care physicians (PCPs) may play a key role in attaining these outcomes by recognizing the signs and symptoms early and making timely referrals. Evaluation of pain in the primary care setting can be complex.
[156] ACR Launches Resource for Primary Care - medcentral.com — The American College of Rheumatology has launched a new online resource to support primary care physicians and advanced practice providers. Called Rheumatology for Primary Care, the website provides tools for identifying rheumatic diseases in adults and children with guidance on early treatment strategies, medications, and when to refer to a specialist.
[157] [Interprofessional Care of Patients with Rheumatoid Arthritis from the ... — Background: General practitioners, specialists, occupational and physical therapists, nursing services and other professional groups are all involved in the treatment of patients with rheumatoid arthritis. This study aims to describe interprofessional cooperation in daily ambulatory care from the perspective of a general practitioner.
[159] The Importance of Interprofessional Collaboration in Healthcare — Interprofessional collaboration is the practice of approaching patient care from a team-based perspective, with a team comprised of multiple health workers with varying professional backgrounds. By implementing interprofessional collaboration into healthcare environments, multiple disciplines can work more effectively as a team to help improve patient outcomes and better the workplace.
[164] Nurses' roles, interventions, and implications for management of ... — Efforts to enhance the role of nurses in rheumatology care are necessary to optimize patient outcomes and meet the evolving needs of individuals with rheumatic diseases. Collaboration across healthcare institutions, professional groups, and educational facilities is necessary for promoting the continual growth and advancement of rheumatology
[166] Interprofessional Collaboration Opportunities ... - The Rheumatologist — Effective interprofessional collaboration is built on a foundation of collegiality, mutual trust and respect, open communication, understanding and appreciation for each member's professional expertise, and shared responsibility and decision-making. 2-4 It involves members of different disciplines working together as a coordinated team to achieve a common goal: providing a level of care that
[167] The Roles of the Interdisciplinary Rheumatology Team in Patient Care ... — To work together effectively, clinicians and rheumatology professionals need to understand the roles of every member of the interdisciplinary team. To enhance this understanding, the ARP Interprofessional Practice & Management Committee has undertaken a project to describe the modern roles of members of the interdisciplinary team in a series of fact sheets. The first three
[168] Interface Management between General Practitioners and Rheumatologists ... — Therefore, communication and information exchange between rheumatologists and GPs needs to be improved, and to this end, referral recommendations were already developed many years ago, at least for RA and AS . This was done in the hope of reducing waiting times in rheumatology outpatient clinics and practices by a better selection of
[170] Facilitators and barriers in diagnosing rheumatoid arthritis as ... — An earlier Norwegian qualitative study has described that GPs often perceive referral to specialist care as an asymmetric process based on little dialog between specialist care and primary care. This was not specifically mentioned by the GPs in our study, however some articulated that referral to rheumatology specialists was perceived as more
[202] The global challenges and opportunities in the practice of rheumatology ... — Any disparity and inadequacy in patient access to healthcare professionals, including primary care providers (PCPs2) rheumatologists, orthopaedic surgeons, physical medicine and rehabilitation specialists, nurses, occupational therapists and physiotherapists can significantly delay diagnosis of RMDs and treatment initiation, both of which are key to minimising disease progression and improving patient outcomes . The International League of Associations for Rheumatology (ILAR) Grants Program also provides opportunities to advance the education and clinical practice of rheumatology in developing countries but has limited resources, with grants totalling $150,000 in 2014. Issues concerning access to clinical care services, rheumatology education and research are particularly problematic in developing countries and rural areas, yet challenges faced in developed countries hinder the progress of RMD healthcare worldwide.
[203] Rheumatology Workforce Shortage: Challenges, Impact, and Solutions — Can you give a brief overview of the workforce shortage? A workforce study conducted by the American College of Rheumatology in 2015 predicted a 100% mismatch between the patient demand for rheumatology providers and the available supply by 2030. What are the main factors contributing to the shortage?
[204] The global challenges and opportunities in the practice of rheumatology ... — With an increasingly ageing population, the prevalence and burden of RMDs are predicted to increase, placing greater demands on the global practice of rheumatology and related healthcare budgets. Effective treatment of RMDs currently faces a number of challenges in both the developed and developing world, and individual countries may face more
[206] Access to rheumatologic care in tropical regions: Barriers and ... — This scarcity of trained rheumatologists places a tremendous burden on the healthcare system which is already flooded with common tropical communicable and non-communicable diseases and leaves many rheumatic disease patients without access to timely or effective care.
[207] Health Disparities in Rheumatology in the United States — Objective: Underserved populations are often at risk of experiencing systematic healthcare disparities. Existing disparities in care access, quality of care received, and treatment outcomes among patients with rheumatic disease are not well understood.
[210] Diagnostic Delay in Rheumatoid Arthritis: A Qualitative Study of ... — Background: To prevent joint damage among patients with rheumatoid arthritis (RA), there is a need to minimize delays from the onset of symptoms until the initiation of appropriate therapy. The present study explored the factors that have an impact on the time it takes for Danish patients with RA to approach their general practitioner (GP) with joint pain, and also how GPs respond to patients
[213] Informing equitable access to care: a cross-sectional study of travel ... — It is important to measure travel burden of people with RA for developing targeted interventions and policies to mitigate identified geographic barriers and informing equitable access to health care. ... and 34 min (IQR: 21-51) to visit rheumatologists. There were significant rural-urban disparities in access to GP and rheumatology care. The
[214] ACR Commends Legislation Addressing Harmful Medicare Payment Cuts to ... — The American College of Rheumatology (ACR) applauded the bipartisan introduction of the Medicare Patient Access and Practice Stabilization Act of 2025, legislation to fully offset the harmful 2.8% cut in the Medicare Physician Fee Schedule (MPFS). The bill, led by Representatives Greg Murphy, MD (R-NC) and Jimmy Panetta (D-CA), includes an additional 2% payment update to physician services
[223] The Challenge of Addressing the Rheumatology Workforce Shortage — The rheumatology workforce faces a deficit of physicians trained to provide high-quality care to patients with rheumatic diseases, and this deficit is projected to worsen over the next 10 to 15 years in many countries and regions around the world. Rheumatology workforce studies carried out in the US, Canada, and in Europe have revealed expected shortages driven by projections for increased
[250] Hotspots and future directions in rheumatoid arthritis-related ... — Of note, the research foci have shifted with time, and the safety and cardiovascular pharmacological mechanism of anti-rheumatoid drugs, especially targeted synthetic DMARDs, are considered to be important research directions in the future. Long-term, robust and well-designed clinical trials deserve further attention.
[251] Environment and systemic autoimmune rheumatic diseases: an overview and ... — Conclusion: Owing to the complexity and multifactorial nature of autoimmune disease, machine learning, a type of artificial intelligence, is increasingly utilized as an approach to analyzing large datasets. Future studies that identify patients who are at high risk of developing autoimmune diseases for prevention trials are needed.
[254] Global Rheumatology Research: Frontiers, Challenges, and Opportunities — However, in many low-resource settings rheumatology remains underdeveloped with regard to health care access, clinical practice, education, training, and research (4).
[255] Diagnosing and treating rheumatic and musculoskeletal diseases in low ... — Also, research conducted in low-resource contexts will benefit the international recommendations by increasing their external validity. Implementation studies and service evaluations are also necessary to ensure recommendations and interventions are applicable and working in low-resource settings.
[256] Rheumatology in Africa-challenges and opportunities - PubMed — There is a need to develop models of care using all categories of health workers and identify prevention strategies and cost-effective management programs for low resource settings. Africa affords an opportunity for collaborative research, including genetic and epigenetic studies, to improve our understanding of many of the rheumatic diseases.
[257] Global Rheumatology Research: Frontiers, Challenges, and Opportunities — The future of global rheumatology research is bright, but there remains much collaborative work to be done, with partners and stakeholders across all regions, to further develop and expand this nascent field. The global rheumatology community is poised to increase its research efforts and to collaborate on innovative topics previously unexplored.
[259] Engaging Patients to Enhance Rheumatology Research — A recent trend to incorporate patient-reported outcomes (PROs) in clinical research, and ultimately clinical practice, is a response to the need to better measure and treat what patients truly care about, and adapt to the changing healthcare environment, which increasingly includes patient satisfaction as a key metric for overall quality of
[261] Unique role of rheumatology in establishing collaborative relationships ... — In this viewpoint paper, we provide evidence for the leading role of rheumatology in developing strategies for engaging patients in research agenda setting, outcome research, developing treatment recommendations, assessing grant applications, conducting patient-centred research and transferring knowledge from research into practice.
[262] Patient and public involvement in research: a review of practical ... — Patient and public involvement (PPI) in every aspect of research will add valuable insights from patients' experiences, help to explore barriers and facilitators to their compliance/adherence to assessment and treatment methods, bring meaningful outcomes that could meet their expectations, needs and preferences, reduce health care costs, and improve dissemination of research findings. It is
[263] New Treatment Approach for Rheumatoid Arthritis Shows Promise in Trial — Results of a Phase 2a clinical trial suggest that peresolimab, an antibody that stimulates the human programmed cell death protein 1 (PD-1) pathway, could be a promising new approach for the treatment of rheumatoid arthritis (RA). The study is published in The New England Journal of Medicine. Exploring new options for rheumatoid arthritis
[264] What are the new drugs for rheumatoid arthritis (RA)? — The newest drugs for the treatment of rheumatoid arthritis are the Janus kinase (JAK) inhibitors, which are FDA approved under the brand names Rinvoq, Olumiant, and Xeljanz.. Janus kinase (JAK) inhibitors work by blocking the activity of one or more of the Janus kinase enzymes (JAK1, JAK2, JAK3, TYK2) in the JAK-STAT signaling pathway, an intracellular pathway that plays a major role in the
[265] New hope for treating rheumatoid arthritis - University of California — A new biodegradable polymer system has been developed to treat rheumatoid arthritis by working in concert ... "This is a very promising line of research utilizing the latest and greatest technology in immunoengineering to combat arthritis," said Iannis Adamopoulous, an associate professor of medicine at Harvard's Beth Israel Deaconess
[266] Biologic Disease-Modifying Therapies: A New Era in Rheumatology — These innovative treatments target specific components of the immune system, providing a more targeted and effective approach compared to traditional therapies. As we delve into the saga of biologic therapies, we uncover how these agents have revolutionized the landscape of rheumatology, offering new hope and improved outcomes for individuals
[267] Innovative Therapies and Strategies for Rheumatoid Arthritis — Ongoing research and clinical trials are crucial for assessing the safety, efficacy, and feasibility of these novel therapies. By overcoming the limitations of conventional treatments and tailoring treatment approaches to individual patients, these innovative therapies have the potential to enhance …
[268] Unlocking the Future: New Biologic Therapies for Rheumatoid Arthritis — The advent of biologic therapies that target specific immune system components (e.g., cytokines, T cells) has transformed RA treatment by offering new management options. Keywords: biologic therapy, disease-modifying antirheumatic drugs (dmards), gene therapy, interleukin blockers, rheumatoid arthritis (ra), tnf inhibitors Unlike traditional DMARDs, biologic DMARDs specifically target immune system cells or proteins involved in the inflammatory process, effectively preventing the chronic destruction of synovial and other tissues caused by RA. In the present review, we discuss the potential of emerging RA biologic therapy centered on RASF (rheumatoid arthritis synovial fibroblasts) triggering molecules, B cell activating factor (BAFF), a protein of the tumor necrosis factor (TNF) family, and alarmins S100 calcium-binding protein A7 (S100A7, also known as psoriasin) and IL-36α in the pathogenesis of RA.
[269] Artificial Intelligence in Rheumatoid Arthritis: Current Status and ... — AI algorithms can facilitate screening and identification of susceptible groups, diagnosis using omics, imaging, clinical, and sensor data, patient detection within electronic health record (EHR), i.e., phenotyping, treatment response assessment, monitoring disease course, determining prognosis, novel drug discovery, and enhancing basic science research. Keywords: Rheumatoid arthritis, Autoimmune diseases, Artificial intelligence, Deep learning, Diagnosis, Imaging, Machine learning, Natural language processing, Precision medicine, Treatment Rheumatoid arthritis (RA) is among the most common rheumatologic diseases.Precision medicine with the aid of artificial intelligence (AI) is becoming more common each day.Numerous machine learning and deep learning algorithms exist that could assist physicians in every step of RA care, including primary prevention, diagnosis, treatment, and rehabilitation.Nonetheless, many challenges exist in the path of expanding AI-guided precision medicine, and especially its application in RA, which could and should be overcome through multi-disciplinary scientific effort.
[271] Machine learning in rheumatology approaches the clinic - Nature — Machine learning and high-throughput technologies hold promise for the classification, diagnosis and treatment of patients with rheumatic diseases, with the ultimate goal of precision medicine.
[272] Artificial intelligence and machine learning in rheumatology — There is a significant opportunity for ML to improve diagnosis and prognosis through analysis of complex patterns in clinical data, medical imaging, and laboratory results. Rheumatology research has witnessed significant advancements in high-throughput technologies, enabling the generation of multi-omics data.
[273] Current Applications and Future Roles of AI in Rheumatology — AI has been used in various conditions in rheumatology. This includes rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), osteoarthritis, systemic lupus erythematosus, systemic sclerosis, and many others. These conditions often present complex diagnostic and treatment challenges. AI has a role in enhancing the understanding of disease, improving accuracy of diagnosis and treatment of
[293] Current Applications and Future Roles of AI in Rheumatology — The strengths of AI can be leveraged in the patient pathway at the diagnosis, disease classification, treatment, and monitoring phases. In RA, deep learning can identify patient clusters that may have different responses to biologic and targeted synthetic disease-modifying antirheumatic drugs.7 By analyzing treatment responses from large patient cohorts, AI can identify which therapies are more effective for specific patient profiles, thereby improving treatment outcomes and minimizing adverse effects. The use of AI also raises ethical questions regarding patient data security, privacy, and potential biases in algorithm training. AI has the potential to revolutionize the management of rheumatic diseases and pave the way for improved patient care and outcomes.